Sanofi US Services Inc.

Registered Principal Details

Business Or Interest:
Prescription drug manufacturing

Lobbying Interests:
prescription drug issues, health care, health insurance

CEO Name:
Paul Hudson

Contact
AT
Andrea Todd-Harlin
1122 E. Pike Street, #1002
Seattle, WA 98122
(651) 341-3444
compliance_wi_sanofi@multistate.us

Authorized Lobbyists

Lobbyist Name Exclusive Duties Authorized On Withdrawn On

Lobbying Interests

Legislative Bills/Resolutions

Assembly Bill 173
Assembly Bill 173
Relating to: regulation of pharmacy benefit managers, fiduciary and disclosure requirements on pharmacy benefit managers, and application of prescription drug payments to health insurance cost-sharing requirements. (FE)

Bill Text and History

For
Notification Date
4/11/2025
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal has not yet communicated on this matter, but intends to do so at a later date.
Assembly Bill 206
Assembly Bill 206
Relating to: the procedure for adding federal newborn screening recommendations to the state-required newborn screenings, granting rule-making authority, and providing an exemption from emergency rule procedures. (FE)

Bill Text and History

For
Notification Date
4/24/2025
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal has not yet communicated on this matter, but intends to do so at a later date.
Senate Bill 145
Senate Bill 145
Relating to: the procedure for adding federal newborn screening recommendations to the state-required newborn screenings, granting rule-making authority, and providing an exemption from emergency rule procedures. (FE)

Bill Text and History

For
Notification Date
4/11/2025
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal has not yet communicated on this matter, but intends to do so at a later date.
Senate Bill 203
Senate Bill 203
Relating to: regulation of pharmacy benefit managers, fiduciary and disclosure requirements on pharmacy benefit managers, and application of prescription drug payments to health insurance cost-sharing requirements. (FE)

Bill Text and History

For
Notification Date
4/21/2025
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal has not yet communicated on this matter, but intends to do so at a later date.

Budget Bill Subjects

Health Services: Departmentwide
Biennial budget bill treatment of matter relating to
Health Services: Departmentwide

Notification Date
2/21/2025
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal has not yet communicated on this matter, but intends to do so at a later date.

Health Services: Medicaid Services
Biennial budget bill treatment of matter relating to
Health Services: Medicaid Services

Notification Date
2/21/2025
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal has not yet communicated on this matter, but intends to do so at a later date.

Insurance: Supervision of the Insurance Industry
Biennial budget bill treatment of matter relating to
Insurance: Supervision of the Insurance Industry

Notification Date
2/21/2025
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal has not yet communicated on this matter, but intends to do so at a later date.

Topics Not Yet Assigned A Bill Or Rule Number

Immunization Regulations
Development, drafting or introduction of a proposal relating to
Immunization Regulations

Action Intended To Affect
Both Legislative matter and rule

Notification Date
6/16/2025
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal has not yet communicated on this matter, but intends to do so at a later date.

Newborn Screening
Development, drafting or introduction of a proposal relating to
Newborn Screening

Action Intended To Affect
Both Legislative matter and rule

Notification Date
6/16/2025
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal has not yet communicated on this matter, but intends to do so at a later date.

Education About Type 1 Diabetes
Development, drafting or introduction of a proposal relating to
Education About Type 1 Diabetes

Action Intended To Affect
Legislative matter

Notification Date
1/29/2025
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal has not yet communicated on this matter, but intends to do so at a later date.

Regulation of Prescription Drugs
Development, drafting or introduction of a proposal relating to
Regulation of Prescription Drugs

Action Intended To Affect
Both Legislative matter and rule

Notification Date
1/16/2025
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal has not yet communicated on this matter, but intends to do so at a later date.

2025-2027 Biennial Budget Bill
Development, drafting or introduction of a proposal relating to
2025-2027 Biennial Budget Bill

Notification Date
1/6/2025
First Communication Date
1/6/2025
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal has communicated on this matter.

Total Lobbying Effort

  2025
January - June
Total
Total Lobbying Expenditures 2025
January - June
$20,250.00
Total $20,250.00
Total Hours Communicating 2025
January - June
4.45
Total 4.45
Total Hours Other 2025
January - June
18.25
Total 18.25

Percent Allocation of Lobbying Effort

Legislative Bills/Resolutions

Relating to: regulation of pharmacy benefit managers, fiduciary and disclosure requirements on pharmacy benefit managers, and application of prescription drug payments to health insurance cost-sharing requirements. (FE)
2025
January - June
2025
July - December
2026
January - June
2026
July - December
Total
2025
January - June
15%
2025
July - December
2026
January - June
2026
July - December
Total 13%
Relating to: regulation of pharmacy benefit managers, fiduciary and disclosure requirements on pharmacy benefit managers, and application of prescription drug payments to health insurance cost-sharing requirements. (FE)
2025
January - June
2025
July - December
2026
January - June
2026
July - December
Total
2025
January - June
15%
2025
July - December
2026
January - June
2026
July - December
Total 13%

Budget Bill Subjects

No budget bill subjects found.

Administrative Rulemaking Proceedings

No administrative rulemaking proceedings found.

Topics Not Yet Assigned A Bill Or Rule Number

2025
January - June
2025
July - December
2026
January - June
2026
July - December
Total
2025
January - June
10%
2025
July - December
2026
January - June
2026
July - December
Total 10%
2025
January - June
2025
July - December
2026
January - June
2026
July - December
Total
2025
January - June
10%
2025
July - December
2026
January - June
2026
July - December
Total 10%

Minor Efforts

(Time spent on matters each of which accounted for less than 10% of the organization's lobbying.)

Minor Efforts
2025
January - June
2025
July - December
2026
January - June
2026
July - December
Total
2025
January - June
50%
2025
July - December
2026
January - June
2026
July - December
Total 50%

Other Matters

No other matters found.

Filed Statements of Lobbying Activity and Expenditures